Poster Sessions Brain Tumor Imaging: Diffusion, MRS & High-Field Imaging Hall B Wednesday 13:30-15:30 2197. Assessment of Invasion and Recurrence in Glioblastoma Multiforme Using Diffusion Weighted MRI Edge Characteristics of Contrast Enhancing Tumor Peter Sherman LaViolette 1,2 , Benjamin M. Ellingson, 2,3 , Jennifer M. Connelly, 2,4 , Mark G. Malkin, 2,4 , Scott D. Rand, 2,3 , Kathleen M. Schmainda 1,2 1 Biophysics, Medical College of Wisconsin, Milwaukee, WI, United States; 2 Translational Brain Tumor Program, Medical College of Wisconsin, Milwaukee, WI, United States; 3 Radiology, Medical College of Wisconsin, Milwaukee, WI, United States; 4 Neurology, Medical College of Wisconsin, Milwaukee, WI, United States Traditionally, brain tumor recurrence is defined as new MRI contrast enhancement apparent in follow-up imaging. This study shows that diffusion weighted MRI edge characteristics of contrast enhancing tumors show measurable differences indicative of tumor invasion prior to contrast enhancing recurrence 2198. Determination of Structural Differences Between Glioblastomas and Metastases by Diffusion Kurtosis Imaging Peter Raab 1,2 , Elke Hattingen 2 , Kea Franz 3 , Friedhelm E. Zanella 2 , Heinrich Lanfermann 1,2 1 Neuroradiology, Hannover Medical School, Hannover, Germany; 2 Neuroradiology, JW Goethe University, Frankfurt/Main, Germany; 3 Neurosurgery, JW Goethe University, Frankfurt/Main, Germany Diffusion kurtosis imaging evaluates the non-Gaussian diffusion pattern of water and indicates tissue structure complexity. In this diffusion study we found differences between glioblastomas and cerebral metastases, that indicate more directed diffusion in glioblastomas and a higher structural complexity in metastases. 2199. Fiber Density Mapping in Patients with Gliomas: Histopathologic Evaluation of a Novel Approach for Post-Processing of DTI Data Andreas Stadlbauer 1,2 , Michael Buchfelder 2 , Oliver Ganslandt 2 1 MR Physics Group, Department of Radiology, Landesklinikum St. Poelten, St. Poelten, Austria; 2 Department of Neurosurgery, University of Erlangen-Nuremberg, Erlangen, Germany To histopathological evaluate fiber density mapping (FDM) in glioma patients for assessment of the extent of destruction of white matter structures in the center, the transition zone and the border zone of gliomas. We correlated FDM-data and histopathological findings from 78 stereotactic biopsies of 20 glioma patients. We found a negative logarithmic correlation of fiber-density with both, % tumor infiltration and tumor cell number. For a tumor infiltration of >60% no fibers are remaining. In tumor regions with
Poster Sessions 2202. Assessment of Diffusion Parameters in Scans Prior to Progression in GBM Patients Following Anti- Angiogenic Therapy Laleh Jalilian 1 , Emma Essock-Burns 1,2 , Susan M. Chang 3 , Soonmee Cha 3,4 , Sarah J. Nelson, 1,4 1 Surbeck Laboratory of Advanced Imaging, Department of Radiology, University of California, San Francisco, San Francisco, CA, United States; 2 UCSF/UCB Graduate Group in Bioengineering, University of California, San Francisco, San Francisco, CA, United States; 3 Department of Neurological Surgery, University of California, San Francisco, University of California, San Francisco, San Francisco, CA, United States; 4 Department of Radiology, University of California, San Francisco, University of California, San Francisco, San Francisco, CA, United States Diffusion-weighted Imaging (DWI) is an important adjunct to standard imaging in the management of GBM patients receiving anti-angiogenic treatments. In this study, ADC values were obtained for a) areas on preprogression scans that ultimately progressed to new contrast-enhancement on progression scans (NEW_CEL), and b) new FLAIR abnormality on preprogression scans with exclusion of areas of contrast enhancement and areas that progress to new contrast-enhancement on progression scans (T2ALL_M). Results demonstrated increasing ADC values in NEW_CEL but no change in T2ALL_M in scans prior to progression. Clinical implications include interpreting new FLAIR abnormality as a consequence of anti-angiogenic treatment alone. 2203. Comparison of Glioma Sub-Populations Using In-Vivo ADC Values and Ex-Vivo 1 H HR-MAS Spectroscopy Adam Elkhaled 1 , llewellyn Jalbert 1 , Hikari Yoshihara 1 , Gaby Bourne 1 , Colleen Cloyd 1,2 , Joanna Phillips 3 , Soonmee Cha 1 , Susan M. Chang 4 , John Kurhanewicz 1,5 , Radhika Srinivasan 1 , Sarah J. Nelson 1,5 1 Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, United States; 2 School of Pharmacy, University of California, San Francisco, United States; 3 Department of Pathology, University of California, San Francisco, San Francisco, CA, United States; 4 Department of Neurological Surgery, University of California, San Francisco; 5 Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, United States Characterization of glioma recurrence and grade transformation has remained elusive. Image-guided biopsies from glioma patients were evaluated using pathology, in-vivo ADC, and ex-vivo proton HR-MAS spectroscopy. Newly diagnosed and recurrent grade IV tissue samples were found indistinguishable from one another. A comparison of recurrent grade IV to recurrent low-grade glioma revealed a significant difference in [myo-inositol] and [creatine]; recurrent low-grades which had upgraded displayed higher total choline compared to non-upgraded and high-grade glioma; the [myo-I]/[total choline] ratio differentiated non-upgraded low-grades from all other cohorts. ADC values demonstrated an inverse relationship with tumor grade and negative correlation with glutathione. 2204. Finding Early Prognostic Marker from 3D 1 H-MRSI and Diffusion Tensor Imaging for Newly- Diagnosed GBM Patients Receiving Radiation, Temozolomide and PKC Inhibitor Ilwoo Park 1,2 , Adam Elkhaled 2 , Achuta Kadambi 2 , Inas Khayal 2 , Nicholas Butowski 3 , Susan M. Chang 3 , Sarah J. Nelson 1,2 1 Joint Graduate group in Bioengineering, University of California San Francisco/Berkeley, San Francisco, CA, United States; 2 Surbeck Laboratory of Advanced Imaging, Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, United States; 3 Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, United States The purpose of this study was to use 3D 1 H MR Spectroscopic Imaging (MRSI) and diffusion tensor imaging (DTI) to develop early prognostic markers for GBM patients undergoing radiation, temozolomide and PKC inhibitor. Twenty-nine patients with newly diagnosed GBM were examined using a 3T MR scanner. Conventional anatomical imaging parameters could not distinguish between progression groups at baseline or 1 month. Parameters derived from MRSI and DTI provided information at baseline and early follow-up examinations that may be valuable in predicting the time-to-progression for patients with GBM. 2205. Longitudinal MRSI Study in Newly Diagnosed Glioblastoma Multiforme Yan Li 1 , Janine M. Lupo 1 , Soonmee Cha 1 , Susan Chang 2 , Sarah J. Nelson 1,3 1 Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, United States; 2 Department of Neurological Surgery, University of California, San Francisco, CA, United States; 3 Department of Bioengineering & Therapeutic Sciences, University of California, San Francisco, CA, United States Glioblastoma Multiforme (GBM) is the most common and malignant type of primary brain tumor, resulting in a median survival of approximately one year. Our study of 18 patients with GBM indicated that metabolic abnormalities more accurately reflect the underlying tumor burden. We found that the Cho to NAA index (CNI) values in the contrast-enhancing lesion (CEL) are elevated at 2 months prior to progression while having less changes in CEL volume at that time. Patients who have a CEL volume with high CNI values are more likely to progress compared with those who have with smaller CEL volume and lower CNI values. We also observed that the regions with high CNI values outside the CEL region could subsequently become enhancing. 2206. 31P and 1H Spectroscopic Imaging of Recurrent Malignant Gliomas Ulrich Pilatus 1 , Joerg Magerkurth 1 , Oliver Bähr 2 , Joachim Steinbach 2 , Elke Hattingen 1 1 Institute of Neuroradiology, University Hospital, Goethe-University, Frankfurt, Germany; 2 Senckenbergisches Institute of Neurooncology, University Hospital, Goethe University Proton and 31P MRSI was performed on human malignant recurrent gliomas in order to provide in vivo analysis of membrane metabolism and neuronal brain damage (tNAA). Phosphorylated components in the membrane metabolism showed clear changes indicating a shift to proliferating cell fractions. While the increase in the phosphocholine/glycerophosphocholine ratio in tumor tissue did not reach significance (p=0.07) the respective ratio for the
- Page 1 and 2:
Poster Sessions TRADITIONAL POSTER
- Page 3 and 4:
Poster Sessions 793. Characterizati
- Page 5 and 6:
Poster Sessions BME increases post-
- Page 7 and 8:
Poster Sessions 814. Impact of Diff
- Page 9 and 10:
825. Assessment of Subchondral Bone
- Page 11 and 12:
Poster Sessions 837. Quantification
- Page 13 and 14:
Poster Sessions 848. Application of
- Page 15 and 16:
Poster Sessions 859. Post-Ischemic
- Page 17 and 18:
Poster Sessions 870. Sodium Concent
- Page 19 and 20:
Poster Sessions 880. High-Resolutio
- Page 21 and 22:
Poster Sessions data using the mult
- Page 23 and 24:
Poster Sessions 902. Regularized Sp
- Page 25 and 26:
Poster Sessions 914. Localized 31 P
- Page 27 and 28:
Poster Sessions 926. Acute Effect o
- Page 29 and 30:
Poster Sessions 938. Determination
- Page 31 and 32:
Poster Sessions 951. In Vivo Temper
- Page 33 and 34:
Poster Sessions 962. Correction of
- Page 35 and 36:
Poster Sessions 975. In Vivo Charac
- Page 37 and 38:
Poster Sessions quantitative sodium
- Page 39 and 40:
Poster Sessions 997. 19 F Magnetic
- Page 41 and 42:
Poster Sessions 1011. Optimized Res
- Page 43 and 44:
Poster Sessions and treatment strat
- Page 45 and 46:
Poster Sessions Electron Spin Reson
- Page 47 and 48:
Poster Sessions University College
- Page 49 and 50:
Poster Sessions 1055. A Hydraulic D
- Page 51 and 52:
Poster Sessions 1065. Levo-Tetrahyd
- Page 53 and 54:
Poster Sessions 1075. A Low-Cost Ex
- Page 55 and 56:
Poster Sessions 1087. Quantitative
- Page 57 and 58:
Poster Sessions distortion, we used
- Page 59 and 60:
Poster Sessions fMRI Modeling & Sig
- Page 61 and 62:
Poster Sessions 1125. Linearity of
- Page 63 and 64:
Poster Sessions contrast mechanisms
- Page 65 and 66:
Poster Sessions Setting appropriate
- Page 67 and 68:
Poster Sessions 1161. A Novel Data
- Page 69 and 70:
Poster Sessions 1172. Resting-State
- Page 71 and 72:
Poster Sessions 1183. Examining Str
- Page 73 and 74:
1195. Complexity in the Spatiotempo
- Page 75 and 76:
Poster Sessions weeks) after experi
- Page 77 and 78:
Poster Sessions 1219. Layer Specifi
- Page 79 and 80:
Poster Sessions 1229. Effects of Do
- Page 81 and 82:
1240. Whole-Heart Water/Fat Resolve
- Page 83 and 84:
Poster Sessions 1252. High Resoluti
- Page 85 and 86:
Poster Sessions 1264. Symptomatic P
- Page 87 and 88:
Poster Sessions 1277. Serial Contra
- Page 89 and 90:
Poster Sessions 1287. Fast Quantita
- Page 91 and 92:
Poster Sessions 1298. Cardiac Free-
- Page 93 and 94:
Poster Sessions Myocardial Perfusio
- Page 95 and 96:
Poster Sessions With the control sy
- Page 97 and 98:
Poster Sessions Flow Quantification
- Page 99 and 100:
Poster Sessions strong similarities
- Page 101 and 102:
Poster Sessions 1354. MRI Measureme
- Page 103 and 104:
Poster Sessions 1366. Volumetric, 3
- Page 105 and 106:
Poster Sessions 1377. T1 Contrast o
- Page 107 and 108:
Poster Sessions 1387. Comparison of
- Page 109 and 110:
Poster Sessions 1400. Measuring Pul
- Page 111 and 112:
Poster Sessions sliding window reco
- Page 113 and 114:
Poster Sessions 1424. Non-Contrast-
- Page 115 and 116:
Poster Sessions 1437. Realtime Cine
- Page 117 and 118:
Poster Sessions calculated, which m
- Page 119 and 120:
Poster Sessions 1462. Dental MRI: C
- Page 121 and 122:
Poster Sessions 1474. A Complementa
- Page 123 and 124:
Poster Sessions Receive Arrays & Co
- Page 125 and 126:
Poster Sessions 1499. A 4-Element R
- Page 127 and 128:
Poster Sessions 1510. Inductive Cou
- Page 129 and 130:
Poster Sessions 1522. Transmit Coil
- Page 131 and 132:
Poster Sessions 1534. Magnetic Fiel
- Page 133 and 134:
Poster Sessions treadmill speed and
- Page 135 and 136:
Poster Sessions correlation. Positi
- Page 137 and 138:
Poster Sessions 1569. White Matter
- Page 139 and 140:
Poster Sessions 1581. On the Influe
- Page 141 and 142:
Poster Sessions 1593. Maximum Likel
- Page 143 and 144:
Poster Sessions 1604. Effects of Tu
- Page 145 and 146:
1615. 3D PROPELLER-Based Diffusion
- Page 147 and 148:
Poster Sessions 1627. A Novel Robus
- Page 149 and 150:
Poster Sessions inhomogeneity-relat
- Page 151 and 152:
Poster Sessions 1651. Repeatability
- Page 153 and 154:
Poster Sessions 1661. Characterizat
- Page 155 and 156:
Poster Sessions 1672. Towards Image
- Page 157 and 158:
Poster Sessions MARDI Hall B Thursd
- Page 159 and 160:
Poster Sessions 1696. In the Pursui
- Page 161 and 162:
Poster Sessions 1708. Hyperammonemi
- Page 163 and 164:
Poster Sessions 1719. Improved Veno
- Page 165 and 166:
Poster Sessions increase in cerebra
- Page 167 and 168:
Poster Sessions 1742. Reduced Speci
- Page 169 and 170:
Poster Sessions 4 Centre for Neuroi
- Page 171 and 172:
Poster Sessions 1766. Combined Asse
- Page 173 and 174:
Poster Sessions Arterial Spin Label
- Page 175 and 176:
Poster Sessions 1788. Joint Estimat
- Page 177 and 178:
Poster Sessions ultrasound disrupti
- Page 179 and 180:
Poster Sessions 1811. MR-Guided Unf
- Page 181 and 182:
Poster Sessions 1821. Optimal Multi
- Page 183 and 184:
Poster Sessions 1834. Quantitative
- Page 185 and 186:
Poster Sessions 1845. Development a
- Page 187 and 188:
Poster Sessions 1856. Post-Mortem I
- Page 189 and 190:
1867. Assessment of Macrophage Depl
- Page 191 and 192:
Poster Sessions 1878. Lipid-Coated
- Page 193 and 194:
Poster Sessions 1890. Thiol Complex
- Page 195 and 196:
Poster Sessions solution results in
- Page 197 and 198:
Poster Sessions 1914. Fluorinated L
- Page 199 and 200: Poster Sessions 1926. T1 Mapping of
- Page 201 and 202: Poster Sessions superparamagnetic i
- Page 203 and 204: Poster Sessions 1948. Fully-Automat
- Page 205 and 206: Poster Sessions 1958. Resting-State
- Page 207 and 208: Poster Sessions 1969. Regional and
- Page 209 and 210: Poster Sessions 1979. White Matter
- Page 211 and 212: Poster Sessions 1989. In Vivo 3D Im
- Page 213 and 214: Poster Sessions 1999. Rates of Brai
- Page 215 and 216: Poster Sessions 2010. Correlation B
- Page 217 and 218: Poster Sessions 2022. Prenatal MR I
- Page 219 and 220: Poster Sessions 2032. Quantitative
- Page 221 and 222: Poster Sessions 2044. Young Adults
- Page 223 and 224: Poster Sessions hyperexcitation in
- Page 225 and 226: Poster Sessions designed to approxi
- Page 227 and 228: Poster Sessions 2078. A New MRI Ana
- Page 229 and 230: Poster Sessions 2090. Absolute Quan
- Page 231 and 232: Poster Sessions 2100. A Voxel Based
- Page 233 and 234: Poster Sessions 2111. Chronic Cereb
- Page 235 and 236: Poster Sessions 2120. Detection of
- Page 237 and 238: Poster Sessions 2130. Relationship
- Page 239 and 240: Poster Sessions was found. However,
- Page 241 and 242: Poster Sessions significant interac
- Page 243 and 244: Poster Sessions 2162. Altered Corti
- Page 245 and 246: Poster Sessions conventional (XRT+c
- Page 247 and 248: Poster Sessions 2182. The Effect of
- Page 249: Poster Sessions 2193. Characterizat
- Page 253 and 254: Poster Sessions 2211. Brain MR Imag
- Page 255 and 256: Poster Sessions coefficient (ADC) a
- Page 257 and 258: Poster Sessions significantly corre
- Page 259 and 260: Poster Sessions 2243. Identifying t
- Page 261 and 262: Poster Sessions 2255. High Resoluti
- Page 263 and 264: Poster Sessions MRA with 1.6mm slic
- Page 265 and 266: Poster Sessions 2277. Investigation
- Page 267 and 268: Poster Sessions 2288. Adaptive Chan
- Page 269 and 270: Poster Sessions 2299. Short-Long Fu
- Page 271 and 272: Poster Sessions 2310. Detection of
- Page 273 and 274: Poster Sessions veins and iron-rich
- Page 275 and 276: Poster Sessions 2334. The Inter-Sca
- Page 277 and 278: Poster Sessions 2345. Quantitative
- Page 279 and 280: Poster Sessions 2356. Early Patholo
- Page 281 and 282: Poster Sessions 2367. Metabolic Pro
- Page 283 and 284: Poster Sessions 2378. Effects of Co
- Page 285 and 286: 2390. In Vitro Proton MRS of Cerebr
- Page 287 and 288: Poster Sessions 2401. Increased Bra
- Page 289 and 290: Poster Sessions the study of large
- Page 291 and 292: Poster Sessions 2423. Diffusion Ten
- Page 293 and 294: Poster Sessions 2433. A DTI-Based A
- Page 295 and 296: Poster Sessions cases on the pathol
- Page 297 and 298: Poster Sessions 2455. Diffusion Ten
- Page 299 and 300: Poster Sessions 2467. Bone Marrow P
- Page 301 and 302:
Poster Sessions 2478. Preliminary R
- Page 303 and 304:
Poster Sessions good visualization
- Page 305 and 306:
Poster Sessions breasts. Here, we s
- Page 307 and 308:
Poster Sessions 2513. Non-Invasive
- Page 309 and 310:
Poster Sessions 2524. Blood Supply
- Page 311 and 312:
Poster Sessions 2534. Detection and
- Page 313 and 314:
Poster Sessions of HP 129Xe in show
- Page 315 and 316:
Poster Sessions that no single exch
- Page 317 and 318:
Poster Sessions 2568. Relaxation of
- Page 319 and 320:
Poster Sessions Hepato-Biliary & Li
- Page 321 and 322:
Poster Sessions 2592. Flip Angle Op
- Page 323 and 324:
Poster Sessions predominately from
- Page 325 and 326:
Poster Sessions 2615. Respiratory N
- Page 327 and 328:
Poster Sessions 2626. Qualitative a
- Page 329 and 330:
Poster Sessions 2636. Could Obesity
- Page 331 and 332:
Poster Sessions 2648. A Novel Whole
- Page 333 and 334:
Poster Sessions diverse duodenal re
- Page 335 and 336:
Poster Sessions 2672. MR Imaging in
- Page 337 and 338:
Poster Sessions 2684. Measuring Glo
- Page 339 and 340:
Poster Sessions Tumor Therapy Respo
- Page 341 and 342:
Poster Sessions 2706. MRI Molecular
- Page 343 and 344:
Poster Sessions 2718. Serial R 2 *
- Page 345 and 346:
Poster Sessions Akaike model select
- Page 347 and 348:
Poster Sessions thyroid tumor model
- Page 349 and 350:
Poster Sessions 2751. Maximizing Ac
- Page 351 and 352:
Poster Sessions 2762. MR Determind
- Page 353 and 354:
Poster Sessions 2774. Multi-Paramet
- Page 355 and 356:
Poster Sessions 2786. 13C HR MAS MR
- Page 357 and 358:
Poster Sessions 2797. Digital Breas
- Page 359 and 360:
Poster Sessions 2808. Clinical Pros
- Page 361 and 362:
Poster Sessions 2819. Perfusion MRI
- Page 363 and 364:
Poster Sessions average flip angle
- Page 365 and 366:
Poster Sessions 2844. Smoothing and
- Page 367 and 368:
Poster Sessions 2857. B1 Insensitiv
- Page 369 and 370:
Poster Sessions iterative SENSE for
- Page 371 and 372:
Poster Sessions optimally utilizing
- Page 373 and 374:
2896. Maxwell's Equation Tailored R
- Page 375 and 376:
Poster Sessions flexibility for cho
- Page 377 and 378:
Poster Sessions 2919. CS-Dixon: Com
- Page 379 and 380:
Poster Sessions 2932. Subtraction i
- Page 381 and 382:
Poster Sessions 2944. Sensitivity o
- Page 383 and 384:
Poster Sessions 2957. T1 Corrected
- Page 385 and 386:
Poster Sessions 2971. Tandem Dual-E
- Page 387 and 388:
Poster Sessions 2983. Magnetic Reso
- Page 389 and 390:
Poster Sessions 2996. Orientation D
- Page 391 and 392:
Poster Sessions 3008. Computer Simu
- Page 393 and 394:
Poster Sessions SSFP Hall B Tuesday
- Page 395 and 396:
Poster Sessions refocusing flip ang
- Page 397 and 398:
Poster Sessions 3043. T2-Prepared S
- Page 399 and 400:
Poster Sessions registered by elast
- Page 401 and 402:
3068. Robust and Fast Evaluation of
- Page 403 and 404:
Poster Sessions 3081. Imaging Near
- Page 405 and 406:
Poster Sessions images using spatia
- Page 407 and 408:
Poster Sessions 3108. Fast Field In
- Page 409 and 410:
Poster Sessions 3120. Assessing the
- Page 411 and 412:
Poster Sessions 3132. Effects of Tr
- Page 413 and 414:
Poster Sessions 3142. Comparison of
- Page 415 and 416:
Poster Sessions 3154. Consistency A